Page last updated: 2024-10-23

betaxolol and Tachycardia

betaxolol has been researched along with Tachycardia in 2 studies

Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Research Excerpts

ExcerptRelevanceReference
" Very mild eye irritation, which was less than that of betaxolol hydrochloride, was observed particularly with BMO maleate, which is an excellent candidate for safe treatment of glaucoma."5.30Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma. ( Barros, MD; Bodor, N; Farag, HH; Prokai, L; Somogyi, G; Wu, WM, 1997)
"Autonomic neural responses to betaxolol are age-dependent in hypertension-related tachycardia."3.88Age-dependent sympathetic neural responses to ß ( Chrostowska, M; Hering, D; Kucharska, W; Narkiewicz, K, 2018)
" Very mild eye irritation, which was less than that of betaxolol hydrochloride, was observed particularly with BMO maleate, which is an excellent candidate for safe treatment of glaucoma."1.30Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma. ( Barros, MD; Bodor, N; Farag, HH; Prokai, L; Somogyi, G; Wu, WM, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hering, D1
Kucharska, W1
Chrostowska, M1
Narkiewicz, K1
Farag, HH1
Wu, WM1
Barros, MD1
Somogyi, G1
Prokai, L1
Bodor, N1

Other Studies

2 other studies available for betaxolol and Tachycardia

ArticleYear
Age-dependent sympathetic neural responses to ß
    Blood pressure, 2018, Volume: 27, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Age Factors; Betaxolol; Blood Pressure; Heart Rate; H

2018
Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.
    Drug design and discovery, 1997, Volume: 15, Issue:2

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Eye; Glaucoma; Intraocular

1997